このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Outpatient Rehabilitation Programmes for Myocardial Ischemia, Heart Failure, and COPD: Satisfaction, Participation, Test Outcomes, and Factors Associated With Positive Changes in Test Results as Well as Level of Participation

2026年5月15日 更新者:Stig Molsted、Nordsjaellands Hospital

Aim The aim of this project is to investigate the level of participation, satisfaction, changes in tests, and factors associated with these results in existing rehabilitation programmes at North Zealand Hospital and in the surrounding municipalities among patients with heart diseases and the lung disease chronic obstructive pulmonary disease (COPD). The project is conducted in clinical practice in a non-selected population.

Participants Individuals with heart disease and COPD who commence training at North Zealand Hospital. Up to 840 participants may be included over a two-year period. Participants will be recruited at the start of training at North Zealand Hospital.

Inclusion criteria:

Patients from North Zealand Hospital (Hillerød and Frederikssund) referred with a rehabilitation plan for group-based rehabilitation for heart disease or COPD at North Zealand Hospital Patient consent to participate in the project. There are no exclusion criteria for the project.

Intervention Participants will be invited to participate in the project when enrolling in the already existing group-based training programme lasting 6-10 weeks as part of rehabilitation for heart disease and COPD.

Data

Participation:

Number of patients commencing the training period relative to the number of patients referred from the cardiology department

Attendance:

Number of completed training sessions relative to the total number of possible training sessions during the periods at the hospital and in the municipalities

Dropout:

Dropout during the hospital-based and municipality-based periods and reasons for dropout The data listed below will, as far as possible, be collected before and after the training period. Physical activity (the final variable) will additionally be measured three months after completion of the municipal programme.

30-second sit-to-stand test* Six-minute walk test* Quality of life measured using the CAT questionnaire for COPD and EQ-5D for the two groups of patients with heart disease Musculoskeletal pain measured using a questionnaire with the Numeric Rating Scale for five body regions Physical activity measured using a modified version of the IPAQ questionnaire from the Danish Health and Morbidity Surveys

*These tests are standard and implemented in the existing rehabilitation programmes.

Other Data

Additional data will include:

From questionnaire: educational level and BMI (height and weight) From patient records: age, sex, treatment for heart disease, and extent of other chronic diseases Data from patient records are already collected as part of routine clinical practice independently of this project.

Ethics Participants will be invited to the study with written and oral information. Participation will take place after informed consent. The study will be conducted in accordance with the regulations of the Scientific Ethical Committee, to which it will be submitted as soon as possible, and it will be reported in the Capital Region of Denmark's legal system via PRIVACY. The study will be registered in the project database www.clinicaltrials.gov. Data will be stored in the REDCap database system.

Dissemination of Results Results will be presented at local and regional meetings and symposia and published in international peer-reviewed scientific journals indexed in PubMed.

調査の概要

状態

まだ募集していません

条件

詳細な説明

Following standard referral after diagnosis of myocardial ischemia, heart failure, or COPD, patients are offered structured outpatient rehabilitation programmes in which supervised physical exercise is a key component. Depending on diagnosis and risk stratification, rehabilitation is delivered at North Zealand Hospital and/or in collaborating municipalities.

This prospective intervention study without a control group is conducted in routine clinical practice. Participants are invited when they enroll in existing group-based rehabilitation programmes. The intervention itself is not experimental and follows standardized, implemented rehabilitation protocols.

Patients with myocardial ischemia and heart failure participate in six weeks of supervised group-based exercise at the hospital, twice weekly, followed by six weeks of rehabilitation in municipal settings. Patients with COPD participate in group-based exercise for up to 12 weeks delivered at the hospital or via telerehabilitation. Exercise sessions include warm-up, aerobic interval training, light resistance training for major muscle groups, and stretching, with intensity guided by the Borg Rating of Perceived Exertion scale.

The primary focus of the study is participation (enrollment, attendance, and dropout) and satisfaction with rehabilitation. Secondary outcomes include changes in physical function, quality of life, musculoskeletal pain, and physical activity. Measurements are obtained before and after the hospital-based rehabilitation period, after any municipal rehabilitation period, and for physical activity additionally at three months after completion.

Sociodemographic and clinical variables obtained from questionnaires and patient records are used to examine factors associated with participation, dropout, and changes in outcomes. The study aims to generate real-world evidence to support optimization of rehabilitation delivery and continuity across healthcare sectors.

Study Type Observational Patient Registry / Prospective Cohort

Conditions

Myocardial Ischemia Heart Failure Chronic Obstructive Pulmonary Disease (COPD)

Interventions Intervention Type: Other Intervention Name: Standard outpatient exercise-based rehabilitation Description: Standardized, guideline-based group exercise programmes delivered as part of routine cardiac and pulmonary rehabilitation (hospital-based, municipal-based, and telerehabilitation).

Outcome Measures Participation and adherence Enrollment rate, attendance rate, and dropout during hospital- and municipality-based rehabilitation Time frame: Up to 12 weeks Satisfaction with rehabilitation (questionnaire) Time frame: End of hospital-based rehabilitation and follow-up 30-second sit-to-stand test Six-minute walk test Time frame: Baseline, post-rehabilitation, and follow-up Quality of life EQ-5D (heart disease) COPD Assessment Test (CAT) Time frame: Baseline, post-rehabilitation, follow-up Musculoskeletal pain Numeric Rating Scale (five body regions) Time frame: Baseline, post-rehabilitation, follow-up Physical activity level Modified IPAQ questionnaire Time frame: Baseline, post-rehabilitation, and three months after completion

Eligibility Criteria Inclusion Criteria Adults referred from North Zealand Hospital (Hillerød or Frederikssund) with a rehabilitation plan for group-based rehabilitation for myocardial ischemia, heart failure, or COPD Enrollment in standard outpatient rehabilitation Provided informed consent Exclusion Criteria None

Enrollment Estimated enrollment: 840 participants

研究の種類

観察的

入学 (推定)

840

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

サンプリング方法

非確率サンプル

調査対象母集団

Patients with heart disease or the lung disease COPD refered to out-patient exercise training during rehabilitation

説明

Inclusion Criteria:

  • Patients from North Zealand Hospital (Hillerød and Frederikssund) referred with a rehabilitation plan for group-based rehabilitation for myocardial ischemia, heart failure, or COPD at North Zealand Hospital
  • Patient consent to participate in the project

Exclusion Criteria:

  • None

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
Rehabilitation group
Patients with heart disease or COPD that are referred to exercise training in a rehabilitation program

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Six minutes walk test
時間枠:from baseline to six weeks and 12 weeks
Distance walked in six minutes
from baseline to six weeks and 12 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
30 sec chair stand test
時間枠:Baseline to six weeks and 12 weeks
Number of repetitions of rises from a chair in 30 sec
Baseline to six weeks and 12 weeks
EuroQol 5-Dimension
時間枠:Baseline to 12 weeks
Quality of life questionaire with index scores from 0-1 and visual analog scale from 0-100, where higher score indicates better health in both
Baseline to 12 weeks
Muscoloskeletal pain
時間枠:Baseline to six weeks and 12 weeks
Muscoloskeletal pain in five body sites Numeric Rating Scale 0-10
Baseline to six weeks and 12 weeks
Physical activity
時間枠:From baseline to 24 weeks
Questionaire fra the Danish Health and Morbidity Survey
From baseline to 24 weeks

その他の成果指標

結果測定
メジャーの説明
時間枠
Dropout of the training intervention
時間枠:Baseline to 12 weeks
Participations' dropout during the training intervention period
Baseline to 12 weeks
Adherence to the training intervention registration
時間枠:Baseline to 12 weeks
Training intervention adherence registered as participation relative to scheduled training sessions in percentage
Baseline to 12 weeks
Satisfaction with treatment questionaire
時間枠:Baseline to 12 weeks
Satisfaction with intervention assessed using a local questionaire with five questions that are replyed from 1-5 where higher score is more agree
Baseline to 12 weeks

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

  • References 1 Dibben GO, Faulkner J, Oldridge N, et al.: Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis. European Heart Journal 2023;44:452.doc:695b90bef87f303feb9c923b1(6) 2 Molloy CD, Long L, Mordi IR, et al.: Exercise-based cardiac rehabilitation for adults with heart failure - 2023 Cochrane systematic review and meta-analysis. European J of Heart Fail 2023;25:2263.doc:695b92b8f87f303feb9c92441(12) 3 Shields GE, Wells A, Doherty P, et al.: Cost-effectiveness of cardiac rehabilitation: a systemat-ic review. Heart 2018;104:1403.doc:695ba4b47d51ae13acc1ab991(17) 4 Tian X, Liu F, Li F, et al.: A Network Meta-Analysis of Aerobic, Resistance, Endurance, and High-Intensity Interval Training to Prioritize Exercise for Stable COPD. COPD 2024;Volume19:2035.doc:695b96e2bcf8ef34cffa42a91 5 Liu S, Zhao Q, Li W, et al.: The Cost-Effectiveness of Pulmonary Rehabilitation for COPD in Different Settings: A Systematic Review. Appl Health Econ Health Policy 2020;19:313.doc:695ba5d16976963cbb24f1161(3) 6 DHRD Årsrapport 2024:doc:695ba9757d51ae13acc1aec91 7 Sommer CG, Jorgensen LB, Blume B, et al. Dropout during a 12-week transitional exercise-based cardiac rehabilitation programme: a mixed-methods prospective cohort study. Eur J Car-diovasc Nurs 2022,21(6):578-86. 8 Ibsen C, Katholm KK, Jakobsen A, et al. Reducing dropout rates in cardiac rehabilitation among cardiac patients in a vulnerable situation: systematic development and feasibility testing of the Heart Priority Programme. BMC Health Serv Res 2024,24(1):1579-x. 9 Mikkelsen T, Korsgaard Thomsen K, Tchijevitch O. Non-attendance and drop-out in cardiac rehabilitation among patients with ischaemic heart disease. Dan Med J 2014,61(10):A4919. 10 Damlund ARS, Jorgensen LB, Blume B, et al. Reasons for dropout in the transition from hospital to municipality during exercise-based cardiac rehabilitation in a Danish cross-sectorial setting: a qualitative study. BMJ Open 2022,12(11):e064660-064660. 11 St

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年8月1日

一次修了 (推定)

2029年3月1日

研究の完了 (推定)

2029年6月30日

試験登録日

最初に提出

2026年5月8日

QC基準を満たした最初の提出物

2026年5月15日

最初の投稿 (実際)

2026年5月18日

学習記録の更新

投稿された最後の更新 (実際)

2026年5月19日

QC基準を満たした最後の更新が送信されました

2026年5月15日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する